For Immediate Release
Chicago, IL – February 9, 2010 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: SAP AG (SAP), International Business Machines Corp. (IBM), Microsoft Corporation (MSFT), Oracle Corporation (ORCL) and CVS Caremark (CVS).
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513
Here are highlights from Monday’s Analyst Blog:
SAP CEO Steps Down
SAP AG (SAP) announced that the SAP Supervisory Board has reached an agreement with CEO Leo Apotheker not to extend his contract as a member of the SAP Executive Board. Leo Apotheker has resigned as CEO and member of the SAP Executive Board effective immediately.
The company said that it would split the leadership between two co-chief executives, naming Bill McDermott, head of field organization, and Jim Hagemann Snabe, head of product development, to those posts.
In addition, Vishal Sikka, Chief Technology Officer, has been appointed to the SAP Executive Board. At the request of the Supervisory Board, Hasso Plattner, Co-Founder of SAP and Chairman of the SAP Supervisory Board, will continue to play a strong role in advising the new leaders on technology and product development.
SAP’s sales fell sharply in September 2008 as companies reduced technology spending during the worldwide economic and financial crisis. But SAP staged a smart recovery on the back of cost rationalization and reported a strong fourth quarter in Jan 2010.
The new setup of the SAP Executive Board will allow SAP to better integrate product innovation with customer needs. SAP AG, together with its subsidiaries, develops, markets, and sells enterprise application software products to corporations, government agencies, and educational institutions in Europe, the Middle East, Africa, North America and Latin America, and the Asia Pacific-Japan region. Major competitors include International Business Machines Corp. (IBM), Microsoft Corporation (MSFT), Oracle Corporation (ORCL).
We currently have a Neutral recommendation on SAP.
CVS Beats by a Penny
CVS Caremark’s (CVS) fourth quarter earnings came in at 79 cents per share, a cent above the Zacks Consensus Estimate of 78 cents and higher than 70 cents reported in the year-ago period. Revenues increased 7% year-over-year to $25.8 billion primarily due to robust growth of both segments - Pharmacy Services and Retail Pharmacy.
For the full-year 2009, CVS reported earnings per share of $2.74 compared to $2.44 in 2008. Revenues recorded a 12.9% growth at $98.7 billion.
We are pleased to see the robust performance of the pharmacy services segment during the reported quarter. Revenues increased 14.5% to $13.5 billion. Revenue growth would have been higher at 18.3% but for the recent generic introductions.
Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5517
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Contact:
Mark Vickery
Web Content Editor
312-265-9380
Visit: www.zacks.com
Zacks Investment Research
